Having trouble viewing this email? View the content as a web page.

HSE Biocides ebulletin

Issued: 15 August 2023

This ebulletin contains information on regulating biocides in Great Britain (GB). 

The GB Biocidal Products Regulation (GB BPR) operates independently from the EU Biocidal Products Regulation (EU BPR), which applies in Northern Ireland.

Separate ebulletins containing information specific to regulating biocides in Northern Ireland are issued as appropriate.

GB active substance expiry date postponed

Active substance expiry date postponed whilst the renewal evaluation is completed in GB

For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the GB BPR.

To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry date of the following approval:

• Creosote (CAS 8001-58-9 EC 232-287-5) in product type 08  
  From 24 July 2023 to 13 February 2025

If you want to supply new biocidal products containing this active substance, you can still apply for GB BPR product authorisation. New products (including new trade names) must not be supplied in GB until product authorisation is granted.

HSE will provide a separate update on the renewal decision when relevant.

Reminder - GB active substance open invitation deadline

Submit a notification by the deadline to keep active substances in the GB Review Programme

HSE has published an open invitation (.pdf) to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the GB Review Programme for the following active substance/product type combination.

Anyone wishing to support one of the active substance/product type combination listed below in GB will need to submit a notification to HSE by the following deadline:

• Silver nitrate (CAS 7761-88-8  EC 231-853-9) in product type 01  
  16 February 2024

If a notification to take over the role of participant is not received, this active substance/product type combination will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market.

HSE will provide separate updates on these where relevant.

If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combination listed above, please contact us.